The study challenges the notion of a “one-size-fits-all” mechanism in bacterial transcription and highlights the diversity of regulatory strategies employed by pathogens.

Recent research shows that tumors in different organs host microbial communities capable of influencing cancer biology, ...

Neurodegenerative diseases, including Alzheimer's disease, Parkinson's disease, amyotrophic lateral sclerosis, and other related disorders, represent a ...

Advancing Global Commercialization Strategy Through CoSara and CoMira Joint VenturesProgressing Clinical Pipeline and Regulatory Pathways for PCR ...

Expanding nucleic acid delivery business with new applications Ongoing optimization of cost structure Advancing plans for spin-off of nucleic acid delivery business and continuing strategic ...

Expanding nucleic acid delivery business with new applicationsOngoing optimization of cost structureAdvancing plans for spin-off of nucleic acid delivery business and continuing strategic repositionin ...

Commercial launch of AlbuFree DX recombinant human albumin by Proliant Health & Biologicals using Dyadic's production platform, with Dyadic eligible to receive a share of profits from product salesExp ...

Exicure, Inc. (Nasdaq: XCUR, the “Company”) releases the following financial results for the year ended December 31, 2025. 2025 Financial Results Cash Position: Cash and cash equivalents were $3.7 ...

Commercial launch of AlbuFree™ DX recombinant human albumin by Proliant Health & Biologicals using Dyadic’s production platform, with Dyadic ...

Life on Earth may have origins from far, far away. Scientists have found a full set of life-building molecules in a nearly ...

In nature, a certain size is often a prerequisite for biomolecules to perform their specific functions. For example, for ...

As part of the settlement, Moderna will pay Arbutus and Genevant $950 million upfront in July 2026 ("Noncontingent Settlement ...